BETAMETHASONE VALERATE

BETAMETHASONE VALERATE was reported 4594 times

BETAMETHASONE VALERATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 58 0.6042
1 VAGINAL FLATULENCE 167 0.5512
2 ANOGENITAL LICHEN PLANUS 7 0.4667
3 PARANEOPLASTIC RASH 7 0.2500
4 SERUM PROCOLLAGEN TYPE III N-TERMINAL PROPEPTIDE INCREASED 4 0.2222
5 PROLONGED EXPIRATION 58 0.2214
6 TOPICAL STEROID WITHDRAWAL REACTION 41 0.1054
7 FEMALE GENITAL TRACT FISTULA 170 0.0995
8 RADICULOPATHY 167 0.0633
9 PROCTITIS 166 0.0592
10 CHRONIC SINUSITIS 217 0.0578
11 SWEATING FEVER 8 0.0576
12 MULTIPLE DRUG THERAPY 43 0.0570
13 MACULAR DEGENERATION 644 0.0539
14 REPETITIVE STRAIN INJURY 6 0.0531
15 NARROW ANTERIOR CHAMBER ANGLE 5 0.0510
16 ACQUIRED PORPHYRIA 3 0.0423
17 DIFFUSE LARGE B-CELL LYMPHOMA STAGE III 3 0.0380
18 GENITAL CANDIDIASIS 8 0.0376
19 NASAL MUCOSAL DISCOLOURATION 6 0.0373
20 STEROID DEPENDENCE 29 0.0330
21 ANAL ERYTHEMA 4 0.0320
22 TOXIC SHOCK SYNDROME 20 0.0317
23 ASPARTATE AMINOTRANSFERASE 7 0.0287
24 CARBOHYDRATE ANTIGEN 27.29 INCREASED 4 0.0267
25 BLEPHAROSPASM 164 0.0260
26 X-RAY ABNORMAL 46 0.0257
27 POST CHOLECYSTECTOMY SYNDROME 7 0.0247
28 GROIN INFECTION 13 0.0236
29 ENDOCRINE OPHTHALMOPATHY 20 0.0230
30 WEANING FAILURE 8 0.0220
31 TENOSYNOVITIS STENOSANS 12 0.0215
32 STEROID WITHDRAWAL SYNDROME 22 0.0215
33 RETINITIS 37 0.0214
34 SERONEGATIVE ARTHRITIS 24 0.0209
35 HISTRIONIC PERSONALITY DISORDER 3 0.0199
36 NEUROPSYCHIATRIC SYNDROME 4 0.0182
37 GRANULOCYTE COUNT INCREASED 7 0.0173
38 VAGINAL DISCHARGE 168 0.0166
39 PNEUMONIA HAEMOPHILUS 8 0.0165
40 DEPRESSIVE SYMPTOM 58 0.0164
41 SKIN DISCHARGE 6 0.0157
42 CATARRH 14 0.0155
43 CANDIDA PNEUMONIA 5 0.0155
44 ANHIDROSIS 6 0.0147
45 PARAESTHESIA ORAL 212 0.0147
46 INTERTRIGO 8 0.0147
47 LUPUS VULGARIS 18 0.0143
48 ORAL CANDIDIASIS 185 0.0140
49 DEEP VEIN THROMBOSIS POSTOPERATIVE 28 0.0140
50 RHEUMATIC FEVER 62 0.0139
51 SWOLLEN JOINT COUNT INCREASED 44 0.0138
52 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 9 0.0135
53 MEAN CELL HAEMOGLOBIN INCREASED 22 0.0133
54 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 4 0.0132
55 BLOOD IMMUNOGLOBULIN A INCREASED 7 0.0130
56 DISLOCATION OF VERTEBRA 29 0.0127
57 BACTERIAL TRANSLOCATION 4 0.0126
58 FACET JOINT SYNDROME 41 0.0126
59 NASAL ULCER 20 0.0125
60 WOUND NECROSIS 6 0.0125
61 EYE INFECTION VIRAL 4 0.0125
62 PENILE OEDEMA 4 0.0123
63 PERIPHERAL VENOUS DISEASE 50 0.0122
64 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 25 0.0121
65 C-REACTIVE PROTEIN 11 0.0119
66 HYPOCHOLESTEROLAEMIA 4 0.0113
67 POST INFLAMMATORY PIGMENTATION CHANGE 5 0.0110
68 URINARY TRACT INFECTION FUNGAL 6 0.0105
69 AMYOTROPHY 4 0.0104
70 RALES 60 0.0103
71 INFLAMMATORY PAIN 7 0.0103
72 URINARY CASTS 4 0.0103
73 RHEUMATOID FACTOR POSITIVE 57 0.0099
74 ARTHRODESIS 10 0.0098
75 URETHRITIS 5 0.0092
76 APPETITE DISORDER 61 0.0092
77 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 8 0.0091
78 RESPIRATION ABNORMAL 62 0.0090
79 BLOOD PRESSURE INADEQUATELY CONTROLLED 54 0.0090
80 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 5 0.0089
81 EXERCISE TOLERANCE DECREASED 51 0.0089
82 SPONDYLITIS 32 0.0088
83 VITAMIN B12 INCREASED 7 0.0088
84 EYELID DISORDER 20 0.0087
85 ECZEMA HERPETICUM 4 0.0086
86 OVERLAP SYNDROME 6 0.0086
87 GLOMERULAR FILTRATION RATE INCREASED 7 0.0085
88 MYOFASCIAL PAIN SYNDROME 6 0.0084
89 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 5 0.0084
90 SKIN ATROPHY 48 0.0083
91 BONE SWELLING 8 0.0083
92 TASTE DISORDER 166 0.0082
93 ELECTRIC SHOCK 7 0.0082
94 NECROTISING OESOPHAGITIS 4 0.0080
95 BURNS SECOND DEGREE 14 0.0080
96 APPENDICOLITH 3 0.0078
97 GASTROINTESTINAL MUCOSAL DISORDER 5 0.0076
98 GINGIVAL DISCOMFORT 5 0.0076
99 GINGIVAL DISCOLOURATION 4 0.0074
100 INFUSION SITE REACTION 22 0.0074
101 BONE EROSION 26 0.0073
102 CUSHING'S SYNDROME 5 0.0072
103 TEMPERATURE REGULATION DISORDER 16 0.0072
104 RHEUMATOID FACTOR INCREASED 8 0.0072
105 BUNION OPERATION 4 0.0071
106 DACTYLITIS 7 0.0071
107 FREQUENT BOWEL MOVEMENTS 191 0.0071
108 TRAUMATIC FRACTURE 5 0.0068
109 DEGENERATIVE BONE DISEASE 3 0.0068
110 SKIN WEEPING 24 0.0067
111 SERRATIA INFECTION 5 0.0067
112 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 114 0.0067
113 PROCEDURAL PAIN 186 0.0067
114 FLANK PAIN 61 0.0065
115 SPONTANEOUS PENILE ERECTION 4 0.0064
116 LIPOHYPERTROPHY 4 0.0064
117 WOUND INFECTION 69 0.0063
118 ONYCHOMADESIS 26 0.0062
119 PUSTULAR PSORIASIS 21 0.0061
120 DUODENAL ULCER PERFORATION 44 0.0059
121 EPILEPSY 177 0.0058
122 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 41 0.0057
123 PORPHYRIA ACUTE 8 0.0056
124 ANTIBODY TEST ABNORMAL 4 0.0056
125 RECTAL HAEMORRHAGE 237 0.0055
126 RED BLOOD CELL SEDIMENTATION RATE INCREASED 60 0.0054
127 SWELLING OF EYELID 34 0.0054
128 INFECTIOUS MONONUCLEOSIS 12 0.0053
129 SYNOVITIS 95 0.0053
130 HEAT STROKE 8 0.0053
131 VASCULITIC RASH 4 0.0052
132 HYPERCHOLESTEROLAEMIA 50 0.0052
133 CLEFT PALATE 10 0.0052
134 PEMPHIGUS 62 0.0050
135 ALCOHOL POISONING 13 0.0048
136 COLITIS 184 0.0048
137 VULVOVAGINAL ERYTHEMA 4 0.0048
138 DENTAL DISCOMFORT 4 0.0048
139 DYSLIPIDAEMIA 24 0.0047
140 IMPETIGO 7 0.0047
141 ANAEMIA MACROCYTIC 10 0.0047
142 ASPARTATE AMINOTRANSFERASE ABNORMAL 7 0.0046
143 COLITIS ULCERATIVE 197 0.0044
144 DISTURBANCE IN SEXUAL AROUSAL 4 0.0043
145 PRURIGO 4 0.0043
146 SYNOVIAL CYST 20 0.0043
147 INCORRECT DOSAGE ADMINISTERED 21 0.0043
148 FUNGAL OESOPHAGITIS 3 0.0043
149 WHITE BLOOD CELLS URINE POSITIVE 8 0.0042
150 INTERVERTEBRAL DISCITIS 8 0.0042
151 FACIAL DISCOMFORT 3 0.0042
152 C-REACTIVE PROTEIN ABNORMAL 27 0.0042
153 BREAST CANCER STAGE III 27 0.0042
154 TELANGIECTASIA 4 0.0041
155 LOWER RESPIRATORY TRACT CONGESTION 7 0.0041
156 CENTRAL OBESITY 3 0.0041
157 HYPOPNOEA 14 0.0040
158 SKIN STRIAE 6 0.0040
159 BRAIN STEM SYNDROME 3 0.0040
160 HAEMATOCHEZIA 218 0.0039
161 INCREASED BRONCHIAL SECRETION 10 0.0039
162 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 275 0.0039
163 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 25 0.0038
164 BODY TEMPERATURE FLUCTUATION 8 0.0038
165 ONYCHOLYSIS 6 0.0038
166 LIVE BIRTH 32 0.0038
167 DISORGANISED SPEECH 7 0.0038
168 INFUSION RELATED REACTION 248 0.0037
169 RASH PUSTULAR 27 0.0037
170 JOINT NOISE 7 0.0036
171 CULTURE URINE POSITIVE 5 0.0036
172 TYMPANIC MEMBRANE PERFORATION 6 0.0035
173 ENTERITIS INFECTIOUS 6 0.0035
174 EXOSTOSIS 32 0.0035
175 MUSCLE INJURY 29 0.0035
176 ACTINIC KERATOSIS 9 0.0035
177 ABDOMINAL LYMPHADENOPATHY 3 0.0035
178 DIABETES MELLITUS INADEQUATE CONTROL 61 0.0034
179 SKIN PLAQUE 29 0.0034
180 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
181 DERMATITIS PSORIASIFORM 7 0.0034
182 ARTERIAL STENOSIS 3 0.0034
183 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 6 0.0034
184 FOLLICULITIS 35 0.0033
185 MONOCYTE COUNT DECREASED 4 0.0033
186 OTITIS EXTERNA 4 0.0033
187 BURSITIS 39 0.0032
188 SPINAL FUSION SURGERY 13 0.0032
189 CONCUSSION 24 0.0031
190 LUPUS-LIKE SYNDROME 28 0.0031
191 LIP DRY 28 0.0031
192 ADJUSTMENT DISORDER 4 0.0031
193 SCIATICA 49 0.0031
194 POLYDIPSIA 12 0.0030
195 BREAST CANCER STAGE II 25 0.0030
196 FOOT DEFORMITY 33 0.0030
197 THROMBOCYTOPENIC PURPURA 4 0.0029
198 PAROSMIA 22 0.0029
199 PERICARDITIS 48 0.0029
200 RHINITIS 23 0.0028
201 PERIPHERAL ARTERY THROMBOSIS 4 0.0028
202 GRIP STRENGTH DECREASED 25 0.0028
203 DEPRESSED MOOD 150 0.0028
204 CHORIORETINOPATHY 4 0.0028
205 GENITAL RASH 4 0.0028
206 ANGINA PECTORIS 79 0.0028
207 GAIT INABILITY 91 0.0027
208 PLANTAR FASCIITIS 9 0.0027
209 BACK INJURY 29 0.0027
210 WHEEZING 157 0.0026
211 WOUND 74 0.0026
212 INFUSION SITE INFECTION 6 0.0026
213 DYSPEPSIA 254 0.0026
214 WALKING AID USER 17 0.0026
215 BLOOD PRESSURE DIASTOLIC DECREASED 19 0.0026
216 VITAMIN D DECREASED 22 0.0026
217 WOUND SECRETION 10 0.0026
218 OSTEOSCLEROSIS 4 0.0025
219 BRONCHIECTASIS 17 0.0025
220 STREPTOCOCCAL INFECTION 14 0.0025
221 ESCHERICHIA TEST POSITIVE 3 0.0025
222 DRUG TOLERANCE DECREASED 7 0.0025
223 FIBULA FRACTURE 7 0.0024
224 BLOOD URIC ACID INCREASED 14 0.0024
225 MIGRAINE 230 0.0024
226 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 4 0.0024
227 GINGIVAL PAIN 19 0.0024
228 JOINT RANGE OF MOTION DECREASED 32 0.0024
229 UPPER RESPIRATORY TRACT INFECTION 110 0.0024
230 MALIGNANT PLEURAL EFFUSION 4 0.0024
231 NEUROGENIC BLADDER 5 0.0024
232 AUTOIMMUNE DISORDER 23 0.0024
233 LOWER RESPIRATORY TRACT INFECTION 106 0.0023
234 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
235 PERSONALITY DISORDER 6 0.0023
236 HAND DEFORMITY 30 0.0023
237 BLISTER 127 0.0023
238 HIRSUTISM 3 0.0023
239 PRESCRIBED UNDERDOSE 45 0.0023
240 SENSORY DISTURBANCE 36 0.0022
241 HELICOBACTER INFECTION 23 0.0022
242 GASTROOESOPHAGEAL REFLUX DISEASE 180 0.0022
243 EYE INFECTION 25 0.0022
244 SKIN WRINKLING 6 0.0022
245 MONOCYTE COUNT INCREASED 8 0.0022
246 TENDON DISORDER 14 0.0021
247 IRRITABLE BOWEL SYNDROME 46 0.0021
248 PRURITUS GENITAL 5 0.0021
249 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
250 C-REACTIVE PROTEIN INCREASED 75 0.0021
251 ADRENAL INSUFFICIENCY 25 0.0021
252 NAIL DISORDER 18 0.0021
253 NIGHT SWEATS 66 0.0020
254 GENERALISED ANXIETY DISORDER 3 0.0020
255 SKIN LACERATION 22 0.0020
256 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
257 AUTOIMMUNE HEPATITIS 14 0.0020
258 DRUG INTOLERANCE 194 0.0020
259 BLOOD PRESSURE SYSTOLIC INCREASED 39 0.0020
260 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
261 EXCORIATION 5 0.0020
262 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
263 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0019
264 ENTHESOPATHY 3 0.0019
265 CUTANEOUS VASCULITIS 7 0.0019
266 SYSTEMIC LUPUS ERYTHEMATOSUS 68 0.0019
267 SLEEP DISORDER 134 0.0019
268 CONTUSION 182 0.0019
269 PULMONARY FIBROSIS 36 0.0019
270 TYPE 2 DIABETES MELLITUS 63 0.0019
271 CUSHINGOID 6 0.0019
272 THROAT CLEARING 7 0.0019
273 LIP SWELLING 62 0.0019
274 EAR PAIN 36 0.0018
275 ANGINA UNSTABLE 12 0.0018
276 EAR CONGESTION 5 0.0018
277 ONYCHOMYCOSIS 8 0.0018
278 OESOPHAGEAL DISORDER 7 0.0018
279 NOSOCOMIAL INFECTION 4 0.0018
280 APHTHOUS ULCER 14 0.0018
281 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
282 LUNG CONSOLIDATION 5 0.0018
283 BLOOD CHOLESTEROL INCREASED 83 0.0018
284 STEVENS-JOHNSON SYNDROME 39 0.0018
285 PSORIASIS 229 0.0018
286 FIXED ERUPTION 3 0.0017
287 CERVICAL VERTEBRAL FRACTURE 6 0.0017
288 RESPIRATORY DISORDER 52 0.0017
289 CARDIAC MURMUR 15 0.0017
290 VITAMIN B12 DEFICIENCY 7 0.0017
291 DYSPNOEA EXERTIONAL 65 0.0017
292 HYPOPITUITARISM 3 0.0017
293 PSORIATIC ARTHROPATHY 70 0.0017
294 ROSACEA 8 0.0017
295 PAIN OF SKIN 46 0.0017
296 DEMYELINATION 7 0.0017
297 OBESITY 27 0.0017
298 NASAL CONGESTION 97 0.0016
299 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 79 0.0016
300 POOR QUALITY SLEEP 35 0.0016
301 ULCER HAEMORRHAGE 11 0.0016
302 BODY TEMPERATURE DECREASED 16 0.0016
303 INJECTION SITE INJURY 9 0.0016
304 SKIN INFECTION 18 0.0016
305 GINGIVAL SWELLING 7 0.0016
306 MEDICATION ERROR 88 0.0016
307 OSTEOARTHRITIS 67 0.0016
308 PRODUCTIVE COUGH 75 0.0016
309 FIBROMYALGIA 38 0.0016
310 MEAN CELL VOLUME INCREASED 4 0.0016
311 LOOSE TOOTH 5 0.0016
312 LIVER INJURY 38 0.0015
313 DRUG DELIVERY SYSTEM ISSUE 3 0.0015
314 PRESCRIBED OVERDOSE 29 0.0015
315 ERYTHEMA 308 0.0015
316 WEIGHT DECREASED 416 0.0015
317 SKIN DISCOMFORT 4 0.0015
318 DERMATITIS ACNEIFORM 9 0.0015
319 SPINAL DISORDER 14 0.0015
320 ARTHROPATHY 82 0.0015
321 DISCOMFORT 90 0.0015
322 INJURY 103 0.0015
323 MUSCLE SPASTICITY 18 0.0015
324 ECZEMA 76 0.0015
325 SOCIAL PROBLEM 6 0.0014
326 JOINT STIFFNESS 38 0.0014
327 LIVER FUNCTION TEST INCREASED 31 0.0014
328 DERMATITIS ALLERGIC 18 0.0014
329 ELECTRIC SHOCK SENSATION 4 0.0014
330 PERIPHERAL SWELLING 220 0.0014
331 MEMORY IMPAIRMENT 196 0.0014
332 CONTRAINDICATED PRODUCT ADMINISTERED 43 0.0014
333 PAPULE 10 0.0014
334 JOINT DISLOCATION 15 0.0014
335 LIP OEDEMA 6 0.0014
336 HYPERPHOSPHATAEMIA 3 0.0014
337 SKIN ULCER 36 0.0014
338 PARAESTHESIA 218 0.0014
339 GLOSSODYNIA 31 0.0014
340 HEPATIC CIRRHOSIS 26 0.0014
341 ARTERIOSCLEROSIS 13 0.0014
342 COGNITIVE DISORDER 64 0.0014
343 HYPOAESTHESIA 202 0.0013
344 SKIN DISCOLOURATION 62 0.0013
345 SKIN REACTION 19 0.0013
346 FEAR OF DEATH 3 0.0013
347 POLYARTHRITIS 7 0.0013
348 CEREBROVASCULAR DISORDER 4 0.0013
349 SCRATCH 14 0.0013
350 LOSS OF EMPLOYMENT 4 0.0013
351 ABDOMINAL PAIN 308 0.0013
352 INJECTION SITE VESICLES 8 0.0013
353 ECTOPIC PREGNANCY 4 0.0013
354 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
355 INFLAMMATION 67 0.0013
356 SKIN DISORDER 43 0.0013
357 ABDOMINAL PAIN UPPER 265 0.0013
358 ERYTHEMA MULTIFORME 12 0.0013
359 NEUTROPHIL COUNT INCREASED 13 0.0013
360 INTERMENSTRUAL BLEEDING 7 0.0013
361 DERMATITIS ATOPIC 66 0.0013
362 VULVOVAGINAL PAIN 6 0.0012
363 RASH VESICULAR 6 0.0012
364 MOBILITY DECREASED 89 0.0012
365 FINGER DEFORMITY 6 0.0012
366 PERIORBITAL SWELLING 7 0.0012
367 PYREXIA 428 0.0012
368 CHOLECYSTITIS ACUTE 7 0.0012
369 UTERINE LEIOMYOMA 9 0.0012
370 AMNESIA 80 0.0012
371 SCAB 14 0.0012
372 SENSITIVE SKIN 9 0.0012
373 RASH PRURITIC 66 0.0012
374 PRODUCT PRESCRIBING ERROR 29 0.0012
375 PELVIC PAIN 22 0.0012
376 STOMATITIS 73 0.0012
377 LOWER LIMB FRACTURE 23 0.0012
378 INCREASED TENDENCY TO BRUISE 11 0.0012
379 ASTHMA 133 0.0012
380 HEPATIC LESION 5 0.0012
381 SKIN EXFOLIATION 96 0.0011
382 ATRIAL FLUTTER 9 0.0011
383 VITAMIN D DEFICIENCY 11 0.0011
384 EAR INFECTION 30 0.0011
385 DELIRIUM 39 0.0011
386 CHEST DISCOMFORT 115 0.0011
387 ABDOMINAL MASS 3 0.0011
388 BONE LESION 4 0.0011
389 NORMAL NEWBORN 6 0.0011
390 BLOOD PHOSPHORUS INCREASED 3 0.0011
391 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
392 MOUTH ULCERATION 23 0.0011
393 PROCTALGIA 7 0.0011
394 DYSURIA 40 0.0011
395 FEEDING DISORDER 22 0.0011
396 TOOTH ABSCESS 11 0.0011
397 NECROSIS 6 0.0011
398 HERPES SIMPLEX 7 0.0011
399 HYPERACUSIS 4 0.0011
400 POLYP 7 0.0011
401 RASH ERYTHEMATOUS 51 0.0011
402 PEMPHIGOID 8 0.0011
403 SWOLLEN TONGUE 33 0.0011
404 HEART RATE DECREASED 37 0.0011
405 RHINORRHOEA 68 0.0011
406 HEART VALVE INCOMPETENCE 3 0.0010
407 POST-TRAUMATIC STRESS DISORDER 7 0.0010
408 ANAEMIA 199 0.0010
409 SKIN SWELLING 9 0.0010
410 IMPAIRED HEALING 34 0.0010
411 JOINT SWELLING 125 0.0010
412 RASH MACULO-PAPULAR 23 0.0010
413 SKIN FISSURES 20 0.0010
414 PHARYNGEAL SWELLING 10 0.0010
415 DRUG ERUPTION 18 0.0010
416 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
417 OESOPHAGEAL PAIN 4 0.0010
418 NASAL DISCOMFORT 8 0.0010
419 CREPITATIONS 3 0.0010
420 MYOSITIS 9 0.0010
421 DERMATITIS 21 0.0010
422 SKIN PAPILLOMA 4 0.0010
423 MOVEMENT DISORDER 32 0.0010
424 PAIN 611 0.0010
425 DRUG TOLERANCE 5 0.0010
426 DUODENITIS 3 0.0010
427 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
428 MALAISE 424 0.0010
429 DIARRHOEA HAEMORRHAGIC 9 0.0010
430 EOSINOPHIL COUNT INCREASED 8 0.0010
431 CONSTIPATION 209 0.0010
432 ROAD TRAFFIC ACCIDENT 40 0.0010
433 SWELLING 89 0.0009
434 TREATMENT NONCOMPLIANCE 52 0.0009
435 NEURALGIA 23 0.0009
436 ULCER 15 0.0009
437 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
438 HYPOGLYCAEMIA 45 0.0009
439 SWELLING FACE 60 0.0009
440 PRURITUS 353 0.0009
441 HIP ARTHROPLASTY 14 0.0009
442 PARONYCHIA 4 0.0009
443 CHOKING SENSATION 5 0.0009
444 CYSTIC FIBROSIS 5 0.0009
445 LUNG DISORDER 44 0.0009
446 TREATMENT FAILURE 74 0.0009
447 MULTIPLE ALLERGIES 7 0.0009
448 IRON DEFICIENCY 4 0.0009
449 IMPAIRED WORK ABILITY 19 0.0009
450 DRY MOUTH 72 0.0009
451 RASH MACULAR 31 0.0009
452 ABNORMAL LOSS OF WEIGHT 6 0.0009
453 ABDOMINAL DISCOMFORT 147 0.0009
454 TEMPERATURE INTOLERANCE 9 0.0009
455 MIOSIS 7 0.0009
456 THERAPEUTIC PRODUCT EFFECT DECREASED 39 0.0009
457 PRODUCT LABEL CONFUSION 5 0.0009
458 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 7 0.0008
459 URTICARIA 142 0.0008
460 INFLUENZA 94 0.0008
461 MATERNAL EXPOSURE DURING PREGNANCY 75 0.0008
462 THERAPEUTIC RESPONSE DECREASED 51 0.0008
463 FEAR OF INJECTION 6 0.0008
464 NASOPHARYNGITIS 155 0.0008
465 SLEEP APNOEA SYNDROME 16 0.0008
466 BLOOD UREA INCREASED 14 0.0008
467 IMPAIRED QUALITY OF LIFE 12 0.0008
468 MUSCULOSKELETAL STIFFNESS 73 0.0008
469 CANDIDA INFECTION 14 0.0008
470 SKIN BURNING SENSATION 59 0.0008
471 DRUG INEFFECTIVE 1081 0.0008
472 SKIN HYPERPIGMENTATION 7 0.0008
473 THROAT TIGHTNESS 22 0.0008
474 LARYNGEAL OEDEMA 5 0.0008
475 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
476 ORGANISING PNEUMONIA 4 0.0008
477 GASTROINTESTINAL DISORDER 72 0.0008
478 OSTEOPOROSIS 33 0.0008
479 BREAST TENDERNESS 6 0.0008
480 ERYSIPELAS 4 0.0008
481 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
482 LYMPHADENOPATHY 28 0.0008
483 VULVOVAGINAL PRURITUS 4 0.0008
484 COORDINATION ABNORMAL 11 0.0008
485 PHARYNGEAL OEDEMA 12 0.0008
486 OEDEMA PERIPHERAL 95 0.0008
487 LYMPHOMA 12 0.0008
488 RASH 338 0.0008
489 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
490 AFFECTIVE DISORDER 6 0.0008
491 SENSITIVITY TO WEATHER CHANGE 4 0.0008
492 ORAL PAIN 17 0.0008
493 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
494 BACTERAEMIA 9 0.0008
495 TRICUSPID VALVE INCOMPETENCE 6 0.0008
496 PRODUCT DISTRIBUTION ISSUE 7 0.0008
497 HYPERPHAGIA 3 0.0008
498 JOINT INJURY 16 0.0007
499 OVERWEIGHT 4 0.0007
500 SQUAMOUS CELL CARCINOMA 7 0.0007
501 SINUSITIS 76 0.0007
502 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 34 0.0007
503 PHOTOSENSITIVITY REACTION 12 0.0007
504 CHEST PAIN 134 0.0007
505 ANGIOEDEMA 32 0.0007
506 ORAL DISCOMFORT 10 0.0007
507 INTRACRANIAL PRESSURE INCREASED 4 0.0007
508 HAEMORRHOIDS 14 0.0007
509 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
510 BLOOD PRESSURE FLUCTUATION 17 0.0007
511 ILL-DEFINED DISORDER 43 0.0007
512 INFECTION 102 0.0007
513 RHEUMATOID ARTHRITIS 80 0.0007
514 OEDEMA 38 0.0007
515 OVARIAN CYST 7 0.0007
516 CHAPPED LIPS 3 0.0007
517 DERMATITIS BULLOUS 5 0.0007
518 PRODUCT USE IN UNAPPROVED INDICATION 171 0.0007
519 VERTIGO 42 0.0007
520 GASTROENTERITIS 10 0.0007
521 EOSINOPHILIA 12 0.0007
522 BEDRIDDEN 9 0.0007
523 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
524 INSOMNIA 181 0.0007
525 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
526 HYPOPHOSPHATAEMIA 5 0.0007
527 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
528 HEADACHE 416 0.0007
529 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
530 FOETAL GROWTH RESTRICTION 4 0.0007
531 HEPATOCELLULAR CARCINOMA 5 0.0007
532 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
533 ARTHRITIS 51 0.0006
534 CONGENITAL ANOMALY 5 0.0006
535 PERSONALITY CHANGE 6 0.0006
536 TENDONITIS 10 0.0006
537 NECK PAIN 36 0.0006
538 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
539 VOMITING 302 0.0006
540 PELVIC FRACTURE 5 0.0006
541 BLOOD TEST ABNORMAL 9 0.0006
542 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
543 PAIN IN JAW 18 0.0006
544 LIVER DISORDER 28 0.0006
545 TINNITUS 29 0.0006
546 HUMERUS FRACTURE 3 0.0006
547 INFUSION SITE PAIN 8 0.0006
548 GUILLAIN-BARRE SYNDROME 3 0.0006
549 RASH GENERALISED 16 0.0006
550 KNEE ARTHROPLASTY 13 0.0006
551 PAIN IN EXTREMITY 181 0.0006
552 DERMATITIS CONTACT 7 0.0006
553 HYPERTENSION 130 0.0006
554 COELIAC DISEASE 6 0.0006
555 NIGHTMARE 21 0.0006
556 LIGAMENT SPRAIN 6 0.0006
557 HYPONATRAEMIA 34 0.0006
558 MADAROSIS 7 0.0006
559 HEMIPLEGIA 5 0.0006
560 RENAL DISORDER 28 0.0006
561 FLUID INTAKE REDUCED 3 0.0006
562 SKIN MASS 4 0.0006
563 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
564 TOXIC SKIN ERUPTION 6 0.0006
565 BREAST MASS 4 0.0006
566 BRONCHITIS 44 0.0006
567 MYALGIA 101 0.0006
568 INTENTIONAL PRODUCT USE ISSUE 52 0.0006
569 PALLOR 16 0.0006
570 FEBRILE NEUTROPENIA 39 0.0006
571 EYE MOVEMENT DISORDER 4 0.0006
572 PSEUDOMONAS INFECTION 5 0.0006
573 SUICIDAL IDEATION 53 0.0006
574 STAPHYLOCOCCAL INFECTION 19 0.0006
575 HYPERTRANSAMINASAEMIA 4 0.0006
576 PRODUCT ODOUR ABNORMAL 6 0.0006
577 MUSCULOSKELETAL PAIN 30 0.0006
578 OFF LABEL USE 500 0.0006
579 SYNCOPE 57 0.0006
580 SPINAL OSTEOARTHRITIS 5 0.0006
581 BLINDNESS UNILATERAL 8 0.0006
582 PURPURA 5 0.0006
583 HAND FRACTURE 4 0.0006
584 RESPIRATORY RATE INCREASED 5 0.0006
585 BRONCHOSPASM 8 0.0006
586 GALLBLADDER DISORDER 10 0.0006
587 ANAL FISSURE 3 0.0006
588 BRUXISM 3 0.0006
589 DISABILITY 11 0.0006
590 GINGIVITIS 3 0.0006
591 THERAPY NON-RESPONDER 25 0.0006
592 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
593 CONFUSIONAL STATE 89 0.0006
594 OPTIC NEURITIS 5 0.0005
595 RESTLESS LEGS SYNDROME 10 0.0005
596 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
597 FLATULENCE 31 0.0005
598 COUGH 153 0.0005
599 DEPRESSION 124 0.0005
600 HYPERKERATOSIS 3 0.0005
601 BURNING SENSATION 38 0.0005
602 DRUG-INDUCED LIVER INJURY 17 0.0005
603 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
604 SKIN HAEMORRHAGE 8 0.0005
605 LOCALISED INFECTION 13 0.0005
606 PLATELET COUNT INCREASED 7 0.0005
607 APPENDICITIS 5 0.0005
608 FACE OEDEMA 9 0.0005
609 GENERAL SYMPTOM 4 0.0005
610 NAUSEA 422 0.0005
611 DYSPNOEA 298 0.0005
612 RED BLOOD CELL COUNT DECREASED 15 0.0005
613 PNEUMONIA ASPIRATION 13 0.0005
614 ALOPECIA 102 0.0005
615 MUSCULAR WEAKNESS 59 0.0005
616 OXYGEN SATURATION DECREASED 29 0.0005
617 BASAL CELL CARCINOMA 8 0.0005
618 MUSCLE SPASMS 94 0.0005
619 HYPERSENSITIVITY 95 0.0005
620 SKIN LESION 14 0.0005
621 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
622 PRURITUS GENERALISED 11 0.0005
623 HEPATITIS 13 0.0005
624 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 91 0.0005
625 RENAL CYST 4 0.0005
626 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
627 HUNGER 7 0.0005
628 GENERAL PHYSICAL HEALTH DETERIORATION 58 0.0005
629 HEPATIC FAILURE 15 0.0005
630 BLOOD PRESSURE DECREASED 33 0.0005
631 CELLULITIS 25 0.0005
632 MYASTHENIA GRAVIS 4 0.0005
633 PRODUCT USE ISSUE 93 0.0005
634 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
635 THROAT IRRITATION 22 0.0005
636 PALPITATIONS 57 0.0005
637 MANIA 8 0.0005
638 GENERALISED OEDEMA 6 0.0005
639 HEPATIC ENZYME INCREASED 33 0.0005
640 CHOLANGITIS 3 0.0005
641 CYST 6 0.0005
642 ARTHRALGIA 201 0.0005
643 BACTERIAL INFECTION 9 0.0005
644 INJECTION SITE HAEMATOMA 7 0.0005
645 IRRITABILITY 29 0.0005
646 ADVERSE DRUG REACTION 43 0.0005
647 BONE PAIN 28 0.0005
648 CONDITION AGGRAVATED 145 0.0005
649 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
650 OROPHARYNGEAL PAIN 44 0.0005
651 DYSPHAGIA 45 0.0005
652 ANAPHYLACTIC REACTION 26 0.0005
653 INTRAOCULAR PRESSURE INCREASED 6 0.0005
654 FACIAL PARALYSIS 4 0.0005
655 GLAUCOMA 9 0.0005
656 ACCIDENTAL OVERDOSE 17 0.0005
657 DRY SKIN 62 0.0005
658 WEIGHT INCREASED 104 0.0005
659 HYPOAESTHESIA ORAL 7 0.0005
660 TACHYCARDIA 41 0.0005
661 TOOTH FRACTURE 5 0.0005
662 LUNG INFILTRATION 4 0.0005
663 ANKLE FRACTURE 7 0.0005
664 HEAD DISCOMFORT 8 0.0005
665 CYSTITIS 14 0.0004
666 PULMONARY HYPERTENSION 9 0.0004
667 BACK PAIN 99 0.0004
668 SEASONAL ALLERGY 6 0.0004
669 FALL 141 0.0004
670 EMOTIONAL DISORDER 13 0.0004
671 PNEUMONIA 136 0.0004
672 VISUAL IMPAIRMENT 52 0.0004
673 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
674 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
675 ATELECTASIS 4 0.0004
676 DIARRHOEA 267 0.0004
677 MENTAL DISORDER 18 0.0004
678 MUSCULOSKELETAL DISCOMFORT 7 0.0004
679 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
680 TENDON RUPTURE 5 0.0004
681 LIMB INJURY 11 0.0004
682 PNEUMONITIS 11 0.0004
683 HAEMATOCRIT DECREASED 8 0.0004
684 PHARYNGITIS 5 0.0004
685 PULMONARY MASS 6 0.0004
686 COLD SWEAT 7 0.0004
687 LYMPHOCYTE COUNT DECREASED 7 0.0004
688 FEELING COLD 11 0.0004
689 SUBARACHNOID HAEMORRHAGE 4 0.0004
690 MOTOR DYSFUNCTION 4 0.0004
691 CHILLS 46 0.0004
692 SEPTIC SHOCK 17 0.0004
693 ROTATOR CUFF SYNDROME 5 0.0004
694 RIB FRACTURE 8 0.0004
695 FOOD ALLERGY 3 0.0004
696 TOOTHACHE 7 0.0004
697 GAIT DISTURBANCE 74 0.0004
698 ANXIETY 110 0.0004
699 HYPOALBUMINAEMIA 3 0.0004
700 LETHARGY 22 0.0004
701 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
702 BLOOD ALBUMIN DECREASED 3 0.0004
703 BREAST PAIN 4 0.0004
704 PHARYNGITIS STREPTOCOCCAL 4 0.0004
705 DEEP VEIN THROMBOSIS 24 0.0004
706 FAECES DISCOLOURED 8 0.0004
707 ASTHENIA 138 0.0004
708 ABNORMAL FAECES 3 0.0004
709 ASPIRATION 4 0.0004
710 HAIR DISORDER 3 0.0004
711 OSTEONECROSIS OF JAW 9 0.0004
712 APPLICATION SITE RASH 5 0.0004
713 MELAENA 8 0.0004
714 APPLICATION SITE PAIN 8 0.0004
715 DIVERTICULITIS 10 0.0004
716 HAEMOGLOBIN DECREASED 37 0.0004
717 DEHYDRATION 48 0.0004
718 DIZZINESS 179 0.0004
719 CARPAL TUNNEL SYNDROME 5 0.0004
720 HYPERGLYCAEMIA 13 0.0004
721 EXPOSURE DURING PREGNANCY 22 0.0004
722 MICTURITION URGENCY 4 0.0003
723 PULMONARY EMBOLISM 33 0.0003
724 DEVICE DEFECTIVE 6 0.0003
725 ABDOMINAL DISTENSION 36 0.0003
726 ORTHOSTATIC HYPOTENSION 6 0.0003
727 HYPERKALAEMIA 12 0.0003
728 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
729 SPINAL PAIN 4 0.0003
730 ASCITES 10 0.0003
731 FATIGUE 264 0.0003
732 LABORATORY TEST ABNORMAL 10 0.0003
733 CHOLELITHIASIS 11 0.0003
734 IMMUNODEFICIENCY 5 0.0003
735 EYE IRRITATION 19 0.0003
736 MOOD ALTERED 9 0.0003
737 NOCTURIA 4 0.0003
738 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
739 HIDRADENITIS 3 0.0003
740 EYE PRURITUS 11 0.0003
741 BLOOD PRESSURE INCREASED 50 0.0003
742 HYPOACUSIS 14 0.0003
743 CONJUNCTIVITIS 6 0.0003
744 HEPATIC FUNCTION ABNORMAL 12 0.0003
745 MIDDLE INSOMNIA 6 0.0003
746 DRY EYE 16 0.0003
747 BRAIN FOG 5 0.0003
748 DYSARTHRIA 12 0.0003
749 PNEUMOTHORAX 5 0.0003
750 RESPIRATORY TRACT CONGESTION 5 0.0003
751 HALLUCINATION, AUDITORY 5 0.0003
752 EYE INFLAMMATION 3 0.0003
753 INCREASED APPETITE 6 0.0003
754 HYPOTHYROIDISM 10 0.0003
755 INJECTION SITE HAEMORRHAGE 25 0.0003
756 ERUCTATION 6 0.0003
757 DECREASED APPETITE 72 0.0003
758 LIVER FUNCTION TEST ABNORMAL 9 0.0003
759 PRODUCT QUALITY ISSUE 42 0.0003
760 SINUS DISORDER 6 0.0003
761 CRYING 11 0.0003
762 BLADDER DISORDER 3 0.0003
763 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
764 ILLNESS 31 0.0003
765 PREGNANCY 6 0.0003
766 CYTOKINE RELEASE SYNDROME 6 0.0003
767 FEAR 8 0.0003
768 EYE SWELLING 11 0.0003
769 UVEITIS 4 0.0003
770 GINGIVAL BLEEDING 4 0.0003
771 HAEMATURIA 10 0.0003
772 HALLUCINATION 22 0.0003
773 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
774 PARANOIA 5 0.0003
775 TOOTH LOSS 6 0.0003
776 EMOTIONAL DISTRESS 35 0.0003
777 LOSS OF CONSCIOUSNESS 37 0.0003
778 SPEECH DISORDER 15 0.0003
779 VISION BLURRED 39 0.0003
780 NEUROPATHY PERIPHERAL 27 0.0003
781 FULL BLOOD COUNT ABNORMAL 3 0.0003
782 LYMPHOPENIA 4 0.0003
783 ACUTE KIDNEY INJURY 43 0.0003
784 THIRST 5 0.0003
785 CARDIOGENIC SHOCK 4 0.0003
786 SKIN CANCER 6 0.0003
787 GOUT 5 0.0003
788 HOT FLUSH 21 0.0003
789 ABDOMINAL PAIN LOWER 7 0.0003
790 OCULAR HYPERAEMIA 13 0.0003
791 DYSPHONIA 16 0.0003
792 COLON CANCER 4 0.0003
793 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
794 COVID-19 47 0.0003
795 RASH PAPULAR 6 0.0003
796 BALANCE DISORDER 23 0.0003
797 HYPERHIDROSIS 34 0.0003
798 INJECTION SITE BRUISING 21 0.0003
799 NEPHROLITHIASIS 12 0.0003
800 GASTRIC HAEMORRHAGE 3 0.0003
801 ADVERSE EVENT 24 0.0003
802 HYPOKALAEMIA 12 0.0003
803 ACUTE RESPIRATORY FAILURE 5 0.0003
804 DEVICE RELATED INFECTION 4 0.0003
805 EYELID OEDEMA 3 0.0003
806 THERAPY PARTIAL RESPONDER 4 0.0003
807 NEOPLASM MALIGNANT 17 0.0003
808 ATAXIA 3 0.0003
809 CATARACT 15 0.0003
810 CHOLECYSTITIS 3 0.0003
811 PREMATURE DELIVERY 4 0.0003
812 SUICIDE ATTEMPT 15 0.0002
813 PANIC ATTACK 9 0.0002
814 BACK DISORDER 4 0.0002
815 PANCREATITIS 13 0.0002
816 HERPES ZOSTER 14 0.0002
817 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
818 HAIR COLOUR CHANGES 3 0.0002
819 HOSPITALISATION 37 0.0002
820 PRODUCT COMPLAINT 6 0.0002
821 APHASIA 7 0.0002
822 DEAFNESS 6 0.0002
823 LOCAL SWELLING 4 0.0002
824 DYSGEUSIA 17 0.0002
825 FEELING HOT 14 0.0002
826 NEUTROPENIA 31 0.0002
827 INTERSTITIAL LUNG DISEASE 11 0.0002
828 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
829 BRADYCARDIA 12 0.0002
830 ADVERSE REACTION 3 0.0002
831 LIMB DISCOMFORT 7 0.0002
832 RENAL IMPAIRMENT 19 0.0002
833 URINARY TRACT INFECTION 38 0.0002
834 FEELING ABNORMAL 53 0.0002
835 OSTEOMYELITIS 4 0.0002
836 LEUKOPENIA 11 0.0002
837 SKIN IRRITATION 10 0.0002
838 HYPOMAGNESAEMIA 3 0.0002
839 HEPATIC STEATOSIS 4 0.0002
840 THINKING ABNORMAL 4 0.0002
841 BLOOD CREATININE INCREASED 14 0.0002
842 PLEURAL EFFUSION 13 0.0002
843 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
844 EYE PAIN 12 0.0002
845 GASTRIC ULCER 4 0.0002
846 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
847 SEIZURE 24 0.0002
848 ANGER 7 0.0002
849 CEREBROVASCULAR ACCIDENT 35 0.0002
850 KIDNEY INFECTION 4 0.0002
851 MENORRHAGIA 4 0.0002
852 CARDIAC DISORDER 19 0.0002
853 HEART RATE INCREASED 20 0.0002
854 SOMNOLENCE 40 0.0002
855 LACRIMATION INCREASED 6 0.0002
856 CARDIOVASCULAR DISORDER 5 0.0002
857 NEUTROPHIL COUNT DECREASED 8 0.0002
858 HYPOPHAGIA 5 0.0002
859 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
860 EJECTION FRACTION DECREASED 3 0.0002
861 EXPOSURE VIA SKIN CONTACT 5 0.0002
862 TREMOR 32 0.0002
863 ACUTE MYELOID LEUKAEMIA 3 0.0002
864 WITHDRAWAL SYNDROME 8 0.0002
865 ANHEDONIA 5 0.0002
866 MOOD SWINGS 6 0.0002
867 EATING DISORDER 4 0.0002
868 BLOOD GLUCOSE DECREASED 9 0.0002
869 FLUSHING 19 0.0002
870 INTESTINAL OBSTRUCTION 7 0.0002
871 ATRIAL FIBRILLATION 18 0.0002
872 BLOOD POTASSIUM INCREASED 3 0.0002
873 INTENTIONAL PRODUCT MISUSE 16 0.0002
874 CARDIAC ARREST 15 0.0002
875 COAGULOPATHY 3 0.0002
876 FUNGAL INFECTION 6 0.0002
877 AGGRESSION 9 0.0002
878 PANCYTOPENIA 10 0.0002
879 PULMONARY OEDEMA 8 0.0002
880 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
881 CIRCULATORY COLLAPSE 3 0.0002
882 INTENTIONAL DOSE OMISSION 5 0.0002
883 THERAPY CESSATION 9 0.0002
884 EPISTAXIS 13 0.0002
885 PRODUCT SUBSTITUTION ISSUE 10 0.0002
886 DIABETES MELLITUS 13 0.0002
887 INFLUENZA LIKE ILLNESS 14 0.0002
888 INJECTION SITE SWELLING 13 0.0002
889 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
890 URINARY INCONTINENCE 5 0.0002
891 DISEASE RECURRENCE 8 0.0002
892 CEREBRAL HAEMORRHAGE 6 0.0002
893 BLOOD POTASSIUM DECREASED 5 0.0002
894 INJECTION SITE RASH 5 0.0002
895 THROMBOSIS 13 0.0002
896 INJECTION SITE REACTION 11 0.0002
897 FRACTURE 3 0.0002
898 BLOOD URINE PRESENT 3 0.0002
899 HAEMATEMESIS 4 0.0002
900 INCORRECT DOSE ADMINISTERED 36 0.0002
901 DEVICE MALFUNCTION 11 0.0002
902 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
903 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
904 ANAPHYLACTIC SHOCK 4 0.0002
905 CHOKING 3 0.0002
906 RESPIRATORY TRACT INFECTION 4 0.0002
907 PRODUCT DOSE OMISSION ISSUE 45 0.0002
908 APPLICATION SITE ERYTHEMA 4 0.0002
909 EYE DISORDER 5 0.0002
910 RESPIRATORY FAILURE 11 0.0002
911 URINARY RETENTION 5 0.0001
912 FULL BLOOD COUNT DECREASED 3 0.0001
913 JAUNDICE 4 0.0001
914 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
915 BONE MARROW FAILURE 3 0.0001
916 COMA 7 0.0001
917 MULTIPLE SCLEROSIS 7 0.0001
918 POLLAKIURIA 6 0.0001
919 NEOPLASM PROGRESSION 5 0.0001
920 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
921 HAEMORRHAGE 15 0.0001
922 RENAL FAILURE 19 0.0001
923 HYPOXIA 5 0.0001
924 RENAL FAILURE ACUTE 6 0.0001
925 FLUID RETENTION 7 0.0001
926 UNDERDOSE 10 0.0001
927 DYSSTASIA 4 0.0001
928 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
929 PSYCHOTIC DISORDER 4 0.0001
930 HYPOTENSION 27 0.0001
931 SEPSIS 15 0.0001
932 INJECTION SITE PAIN 41 0.0001
933 CORONARY ARTERY DISEASE 4 0.0001
934 MYOCARDIAL INFARCTION 23 0.0001
935 NERVOUS SYSTEM DISORDER 4 0.0001
936 DEPENDENCE 7 0.0001
937 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
938 HEAD INJURY 4 0.0001
939 DIABETIC KETOACIDOSIS 3 0.0001
940 HIP FRACTURE 4 0.0001
941 DEVICE ISSUE 11 0.0001
942 ENCEPHALOPATHY 3 0.0001
943 VISUAL ACUITY REDUCED 4 0.0001
944 AGEUSIA 3 0.0001
945 ACNE 9 0.0001
946 GASTRIC CANCER 3 0.0001
947 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
948 ERECTILE DYSFUNCTION 3 0.0001
949 THROMBOCYTOPENIA 13 0.0001
950 DIPLOPIA 3 0.0001
951 GASTRITIS 3 0.0001
952 PLATELET COUNT DECREASED 12 0.0001
953 CARDIAC FAILURE 9 0.0001
954 DISTURBANCE IN ATTENTION 6 0.0001
955 DRUG INTERACTION 17 0.0001
956 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
957 HYPERSOMNIA 3 0.0001
958 DISORIENTATION 4 0.0001
959 DYSKINESIA 4 0.0001
960 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
961 BLINDNESS 4 0.0001
962 LUNG NEOPLASM MALIGNANT 4 0.0001
963 CHRONIC KIDNEY DISEASE 7 0.0001
964 EXPIRED PRODUCT ADMINISTERED 3 0.0001
965 CARDIAC FAILURE CONGESTIVE 7 0.0001
966 BLADDER CANCER 5 0.0001
967 DRUG ABUSE 7 0.0001
968 DRUG DEPENDENCE 13 0.0001
969 PRODUCT DOSE OMISSION 5 0.0001
970 ABNORMAL BEHAVIOUR 3 0.0001
971 DRUG EFFECT DECREASED 4 0.0001
972 OVERDOSE 16 0.0001
973 DEVICE BREAKAGE 3 0.0001
974 DEVICE LEAKAGE 3 0.0001
975 DEVICE DISLOCATION 3 0.0001
976 PRODUCT STORAGE ERROR 6 0.0001
977 DRUG WITHDRAWAL SYNDROME 6 0.0001
978 SURGERY 4 0.0001
979 AGITATION 5 0.0001
980 UNEVALUABLE EVENT 5 0.0001
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
982 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
983 DEATH 44 0.0001
984 INJECTION SITE ERYTHEMA 6 0.0000
985 BLOOD GLUCOSE INCREASED 8 0.0000
986 DRUG DOSE OMISSION BY DEVICE 3 0.0000
987 DISEASE PROGRESSION 4 0.0000
988 NO ADVERSE EVENT 6 0.0000